MARKET

BKYI

BKYI

BIO-Key International Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.590
-0.030
-0.83%
Closed 18:59 12/03 EST
OPEN
3.600
PREV CLOSE
3.620
HIGH
3.650
LOW
3.470
VOLUME
229.04K
TURNOVER
--
52 WEEK HIGH
20.64
52 WEEK LOW
2.750
MARKET CAP
28.01M
P/E (TTM)
-0.4354
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Healthcare Biometrics Market Research Report by Type, by Application, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
, /PRNewswire/ --Read the full report: The Global Healthcare Biometrics Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 15.50%.Market Segmentation & Coverage:This research report categorizes the Healthcare Biometrics to forecast the revenues and analyze the trends in each of the following sub-markets:Based on Type, the Healthcare Biometrics Market studied across Multi factor authentication, Multimodal authentication, and Single factor recognition. Based on Application, the Healthcare Biometrics Market studied across Care provider authentication, Home/remote patient monitoring, Medical Record Security & Data Center Security, Patient Identification & Tracking, and Pharmacy dispensing. Based on End-user, the Healthcare Biometrics Market studied across Healthcare institutions, Hospitals & Clinics, and Research & Clinical laboratories. Based on Geography, the Healthcare Biometrics Market studied across Americas, , and , & . The Americas region surveyed across , , , , and . The region surveyed across , , , , , , , , and . The , & region surveyed across , , , , , , , , , , and . Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Healthcare Biometrics Market including Company, Aware Inc., BIO-key International, Inc., BioEnable Technologies Pvt. Ltd., Biometrics Research Group Inc., Fujitsu Limited, Genkey Solutions B.V., Genkey Solutions B.V., HID Global, Hitachi Ltd., Imprivata, Inc. by , LLC, M2SYS LLC, NEC Corporation, Nuance Communications, Inc., Qualcomm Technologies, Inc., Safran S.A., Siemens AG, Suprema Inc., Thales Group, and ZKTECO CO., LTD. FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare Biometrics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments1. What is the market size and forecast of the Global Healthcare Biometrics Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare Biometrics Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare Biometrics Market?4. What is the competitive strategic window for opportunities in the Global Healthcare Biometrics Market?5. What are the technology trends and regulatory frameworks in the Global Healthcare Biometrics Market?6. What are the modes and strategic moves considered suitable for entering the Global Healthcare Biometrics Market?Read the full report: About ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare:  US: (339)-368-6001 Intl: +1 339-368-6001 
PR Newswire - PRF · 2d ago
BIO-key Launches PortalGuard IDaaS Cloud Authentication Solution
BIO-key Launches PortalGuard IDaaS (Identity-as-a-Service) Cloud Authentication Solution, Enabling Secure and Flexible Identity & Access Management WALL, N.J., Nov. 30, 2020 (GLOBE NEWSWIRE) -- BIO-key
Benzinga · 3d ago
BIO-key Launches PortalGuard IDaaS (Identity-as-a-Service) Cloud Authentication Solution, Enabling Secure and Flexible Identity & Access Management
GlobeNewswire · 3d ago
Identity and Access Management Provider BIO-key Presents at Imperial Capital Virtual Security Investor Conference Wednesday, December 2nd
BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that its Chairman & CEO Michael DePasquale will present at the 17th Annual Imperial Capital Security Investor Conference on Wednesday, December 2, 2020 at 12:30 pm ET. The Conference will connect approximately 70 public and private security-focused companies with 500 key investors and business leaders. For health and safety reasons, this year's conference will take place virtually over two days December 2-3, 2020.
GlobeNewswire · 11/25 13:12
Identity and Access Management Provider BIO-key Presents at Imperial Capital Virtual Security Investor Conference Wednesday, December 2nd
WALL, N.J., Nov. 25, 2020 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that its Chairman & CEO Michael DePasquale will present at the 17th Annual Imperial Capital Security Investor Conference on Wednesday, December 2, 2020 at 12:30 pm ET. The Conference will connect approximately 70 public and private security-focused companies with 500 key investors and business leaders. For health and safety reasons, this year’s conference will take place virtually over two days December 2-3, 2020. Now in its 17th year, Imperial Capital’s Security Investor Conference remains the security industry’s leading investor conference, bringing together a select group of companies to present their positioning and strategic growth plans to key investors and business leaders. This virtual gathering of presenting companies and executives with institutional and private equity investors provides an opportunity to learn about companies delivering the latest in compelling security solutions across global Consumer, Enterprise and Government markets.About Imperial Capital, LLC (www.imperialcapital.com) Imperial Capital is a full-service investment bank offering comprehensive suite of services, including sales and trading, capital markets and restructuring, research and investment banking advisory, to institutional investors and middle market companies.About BIO-key International, Inc. (www.bio-key.com) BIO-key is revolutionizing authentication with biometric centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provide convenient and secure access to devices, information, applications and high-value transactions. BIO-key’s proprietary software and hardware solutions, with industry leading biometric capabilities, enable large-scale on-premise and Identity-as-a-Service (IDaaS) solutions as well as customized enterprise and cloud solutions.Engage with BIO-key  Facebook – Corporate:BIO-key International Twitter – Corporate:@BIOkeyIntl Twitter – Investors:@BIO_keyIR StockTwits:BIO_keyIR Investor & Media Contacts William Jones, David Collins Catalyst IR 212-924-9800 bkyi@catalyst-ir.com
GlobeNewswire · 11/25 13:02
Identity and Access Management Provider BIO-key Partners with Prominic.NET to Provide Advanced, Flexible User Authentication Security for U.S. DoD Agency
BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that it has partnered with Prominic.NET, an owner and operator of data centers serving businesses running on HCL Digital Solutions (formerly IBM Collaboration) products, to deploy BIO-key's PortalGuard IAM solution to a U.S. DoD agency. PortalGuard will provide enhanced user access security to the agency's enterprise applications and data via secure smart card authentication.
GlobeNewswire · 11/23 12:58
Identity and Access Management Provider BIO-key Partners with Prominic.NET to Provide Advanced, Flexible User Authentication Security for U.S. DoD Agency
WALL, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that it has partnered with Prominic.NET, an owner and operator of data centers serving businesses running on HCL Digital Solutions (formerly IBM Collaboration) products, to deploy BIO-key's PortalGuard IAM solution to a U.S. DoD agency. PortalGuard will provide enhanced user access security to the agency’s enterprise applications and data via secure smart card authentication. BIO-key implemented its PortalGuard IAM solution on the enterprise-grade HCL Domino-based environment to support application access requirements for the DoD agency’s mission-critical environment. PortalGuard is being used as a Security Assertion Markup Language (SAML) Identity Provider to provide Single Sign-On (SSO) capabilities for the load-balanced environment. PortalGuard is also being used to configure support for Personal Identity Verification (PIV) credential smart card authentication that enables access to application data. In addition, PortalGuard provided a split login experience where users without a PIV credential smart card could still login manually using traditional two-factor authentication methods, showcasing the solution's flexibility in supporting different user types and access conditions."We are proud and excited to be selected for this important DoD application environment," stated Mark Cochran, President of BIO-key - PortalGuard. "PortalGuard delivers a complete IAM solution for both on-premises and SaaS offerings that give customers the flexibility to choose based on their application security needs and Time to Value expectations. The combination of single-sign-on and multifactor authentication capabilities allows PortalGuard to provide a higher level of configurable security to protect our customer's critical systems and data."About BIO-key International, Inc. (www.bio-key.com) BIO-key is revolutionizing authentication with biometric solutions that enable convenient and secure access to devices, information, applications, and high-value transactions. BIO-key's software and hardware finger scanning solutions offer secure, user-friendly, and attractively-priced alternatives to passwords, PINs, tokens, and security cards, enabling enterprises and consumers to secure their networks and devices as well as their information in the cloud.BIO-key Safe Harbor Statement All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology industry; market acceptance of biometric products generally and our products under development; our ability to execute and deliver on contracts in Africa; our ability to expand into Asia, Africa and other foreign markets; our ability to integrate the operations and personnel of PistolStar into our business; the duration and severity of the current coronavirus COVID-19 pandemic and its effect on our business operations, sales cycles, personnel, and the geographic markets in which we operate; delays in the development of products and statements of assumption underlying any of the foregoing as well as other factors set forth under the caption see "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019 and other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, the Company undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Additionally, there may be other factors of which the Company is not currently aware that may affect matters discussed in forward-looking statements and may also cause actual results to differ materially from those discussed. In particular, the consequences of the coronavirus outbreak to economic conditions and the industry in general and the financial position and operating results of our company in particular have been material, are changing rapidly, and cannot be predicted.Facebook – Corporate: Twitter – Corporate: Twitter – Investors:  StockTwits:BIO-key International @BIOkeyIntl @BIO_keyIR BIO_keyIR Investor & Media Contacts William Jones, David Collins Catalyst IR 212-924-9800 bkyi@catalyst-ir.com
GlobeNewswire · 11/23 12:58
Following Approval at its Special Meeting of Shareholders, BIO-key Announces 1-for-8 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Price Requirement
BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and other multi-factor identity and access management (IAM) solutions for strong, convenient authentication and large-scale identity applications, today announced that the Company's Board of Directors has approved a 1-for-8 reverse stock split that is expected to become effective on November 20, 2020. On November 16th, BIO-key shareholders approved an amendment to the Company's Certificate of Incorporation to effect a reverse split at a ratio between 1-for-4 and 1-for-10, with the final ratio determined by the Company's Board of Directors. Pursuant to the reverse split, BIO-key shareholders will receive one (1) new share of common stock for every eight (8) shares held prior to the effective date. Any fractional shares will be rounded up to the next whole share and shareholders will not receive cash in lieu of any such fractional shares. BIO-key expects to commence trading on the Nasdaq Capital Market on a split-adjusted basis on November 20, 2020.
GlobeNewswire · 11/19 13:05
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BKYI. Analyze the recent business situations of BIO-Key International Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average BKYI stock price target is 2.000 with a high estimate of 2.000 and a low estimate of 2.000.
EPS
Institutional Holdings
Institutions: 29
Institutional Holdings: 441.19K
% Owned: 5.66%
Shares Outstanding: 7.80M
TypeInstitutionsShares
Increased
3
98.19K
New
16
129.90K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Electronic Equipments & Parts
+0.68%
Technology Equipment
+0.10%
Key Executives
Chairman/Chief Executive Officer/Director
Michael DePasquale
Co-Chairman/Director
Kwok Fong Wong
Chief Financial Officer
Cecilia Welch
Senior Vice President
James Sullivan
Chief Technology Officer
Mira LaCous
Director
Emmanuel Alia
Vice President
Kimberly Johnson
Director
Manny Alia
Independent Director
Thomas Bush
Independent Director
Thomas Gilley
Independent Director
Pieter Knook
Independent Director
Robert Michel
Director
Jianhui Yau
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About BKYI
BIO-key International, Inc. develops and markets fingerprint biometric identification and identity verification technologies, cryptographic authentication-transaction security technologies, as well as related identity management and credentialing software solutions. The Company is also engaged in developing automated, finger identification technology that supplements or compliments other methods of identification and verification, such as personal inspection identification, passwords, tokens, smart cards, identity cards, public key infrastructure (PKI), credit card, passports, driver's licenses, one-time password (OTP) or other form of possession or knowledge-based credentialing. Its solutions identify individuals and verify, or confirm, their identity before granting access to, among other things, corporate resources, subscribed data and services, Web portals, applications, physical locations or assets.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of BIO-key International, Inc. stock information, including NASDAQ:BKYI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BKYI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BKYI stock methods without spending real money on the virtual paper trading platform.